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Medical Practice
Aims & rationale
Many medicines prescribed in general practice require a dosage change as kidney
function routinely declines with aging. Presently there lacks a systematic approach
to identifying the patients at risk of a medication-related adverse event. The aim of
this preliminary research was to investigate how kidney function is assessed and the
appropriateness of use of medications in this general practice, in a population 65
years or older, by engaging a clinical pharmacist.
Methods
The first stage of the research was to retrospectively estimate the kidney function,
via the Cockcroft-Gault equation (used for drug-dosing) and compare this with the
measure of kidney function, the eGFR (estimated Glomerular Filtration Rate)
provided by laboratories, of the recruited patients. Medications known to require
attention when used in kidney impairment were recorded if used and their
appropriateness analysed.
Findings
The kidney function and medicines of 96 patients were assessed retrospectively.
The mean estimates of kidney function using the two assessments were statistically
significantly different (45mL/min vs 63mL/min/1.73m2, p<0.0001). Over half (56%) of
the patients had some degree of kidney impairment; 51 individual medicines that
require attention in kidney impairment were prescribed. The majority of usage was
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Intended use Staging in kidney 
disease 
Drug dosing 
Availability Routinely reported by 
laboratories 
Calculated  
Best Practice™ medical 
software AND 
MDCalc 
Significance eGFR < 60mL/
min/1.73m2—stage 3 
CKD 
Reduce dose/ caution 
  some meds CrCl< 60mL/
min 




Stages of kidney impairment3 
Estimates of kidney function 
 Glomerular filtration rate Creatinine clearance 
Known as: eGFR eCRCl 
Availability: Routinely reported by labs 
Calculated using: 
 medical software 
 MDCalc© 




- marker of CKD (stage 3a) 
 
Reduce drug dose/ precautions with: 
 some medicines if < 60mL/min 
 many medicines if < 50mL/min 
How GPs can assess kidney 
function: 
  eCrCl calculated using  
  Best Practice™ clinical  tools  
  reported eGFR  
 
Kidney function declines with age. Many medicines 
require care when used in older people. GPs’ self-
reported errors1 and medication-related hospital 
admissions2 suggest that management could be improved. 
In a population 65 years or older, to investigate:  
 how kidney fu ction is assessed; and 
 the appropriateness of use of medications in the presence of 
reduced kidney function; 
in this general practice, by engaging a clinical pharmacist. 
After consent, patients’ records were retrospectively reviewed by 
the pharmacist, for 2 years for: 
 measures of kidney function (serum 
creatinine, eGFR); and 
 medications that require caution in 
reduced kidney function. 
Estimates of kidney function were compared 
and medicines were assessed for 
appropriateness, based on current 
recommendations for dosing and monitoring 
when kidney function is reduced. 




Records of 96 patients were reviewed. 
Kidney function: 
 All patients reviewed had kidney 
function assessed; 
 CrCl was not estimated for patients 
to guide drug-dosing; 
 cohort means of eGFR & estimated 
CrCl were statistically significantly 
different:  
63mL/min/1.73m2 vs 45mL/min, 
p<0.0001). See Figure. 
 Over half (56%) had reduced kidney 
function requiring caution with medicines 
Appropriateness of medicines: 
 64% of medicines used in patients with impaired kidney function were 
managed appropriately for degree of kidney impairment 
Case 1 (from review) 
 85 year-old female; medical history of hypertension, 
osteoarthritis, vascular disease, haematuria, osteopenia, atrial 
fibrillation and history of stroke 
 Commenced dabigatran 150mg (an anticoagulant) twice daily; 
to reduce her risk of stroke. 
 Admitted to hospital with upper GIT haemorrhage.  
 eGFR 31 – 42 mL/min/ 1.73m2; eCrCl 23- 30mL/min. 
 Dabigatran contraindicated  
Why worry about kidney function? 
Case 2 (from review) 
 88 year old female; medical history of diabetes, 
heart failure, polymyalgia rheumatic; osteopenia 
 Commenced pregabalin 75mg twice daily 
(neuropathic pain) 
 Confused, drowsy; two falls in 2 days. 
 eGFR 40mL/min/1.73m2; eCrCl 25mL/min 
 recommended dose 25- 50mg daily (⅓ dose given) 
 
From the analysis of appropriateness of medicines, GPs developed the list of TARGET 
medicines; for “recall & review” of patients 
Reference 
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 Target medicines 
  Relevance to research and practice needs  
Although the majority of medicines are managed appropriately, the engagement of 
the pharmacist has helped identify medicines to target in this “high-risk” population. 
Feedback, recall and review are underway to improve the quality use of these 
medicines within this general practice. 
Figure: Means of estimates of kidney function, from 
reported eGFR and calculated creatinine clearance (using 
ideal body weight) for patient cohort 
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Medicines and groups Use with reduced kidney function 
anticoagulants (non-








Risk of low blood sugar 
Targets relaxed for people with comorbidities 
  metformin Low dose; risk of adverse effects 
digoxin 
  Monitor kidney function and potassium 
Digoxin levels at 6 hours after last dose 
statins e.g. simvastatin 80mg Contra-indicated 
pregabalin (Lyrica™) 
Lower starting doses and maximum dose 
Adverse effects+++ 
* newer antidiabetic agents (SGLT2 inhibitors) also require caution but were not used in this practice 
appropriate; medicines identified as requiring more attention included non-vitamin K
oral anticoagulants, pregabalin, digoxin, nitrofurantoin, simvastatin, metformin and
allopurinol.
Relevance to policy, research and/or practice needs
This general practice manages medicines in a high-risk population appropriately in
most instances. Following research will be to assess the implementation of practice
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